Physician profile
Samuel Kim
NPI 1285052787
$909.11
in general payments reported to CMS, 2019-2025
9 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $424 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $196.60 | 2024-2025 | Na, Trumatch, Matrixmandible |
| Medtronic, INC. | $171.93 | 2024 | Onyx Frontier |
| Endo USA, INC. | $149.36 | 2024 | Xiaflex |
| Axogen | $137.71 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $109.43 | 2025 | Libtayo |
| Amgen INC. | $50.00 | 2024 | Repatha |
| Medical Device Business Services, INC. | $40.59 | 2025 | Va-Lcp |
| Davol INC. | $36.92 | 2025 | Arista |
| Octapharma USA, INC. | $16.57 | 2025 | Balfaxar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.